medigraphic.com
ISSN 2007-8013 (Print)
Órgano oficial de la Universidad Autónoma de Sinaloa

2020, Number 3

<< Back Next >>

Rev Med UAS 2020; 10 (3)

Benign adnexal mass recurrence presented in a 5 years period in a second level hospital

León-Gil MS, Morgan-Ortiz F, Peraza-Garay F

Language: Spanish
References: 21
Page: 112-117
PDF size: 137.26 Kb.


ABSTRACT

Objective: To evaluate the benign adnexal mass recurrence presented in a five year period of time in Culiacan’s Civil Hospital. Material and Methods: Observational, descriptive, retrolective study. We researched all medical records of patients with adnexal mass diagnosis who required surgical intervention by laparoscopy or abdominal laparotomy approach in Culiacan’s Civil Hospital, during 2014 to 2019. Then we followed them to detect recurrence. We analyzed the adnexal mass recurrence, the most common histological type and the one that recurred more frequently, as well as the presence of contralateral recurrence and mean age at presentation. Results: We study a total of 252 patients, who presented a 7.5% recurrence (n=19), with a mean age of 33.9 years. The most frequent histological type was serous cistoadenoma with a 25% (n=5) but endometrioma presented higher recurrence with 26.3% (n=5). Laparotomy was made in 54.8% (n=138) patients, and 45.2% (n=114) by laparoscopy. Contralateral recurrence was present in a 2.4% (n=6). Laparoscopy and cystectomy presented higher recurrence rate with 9.6% (n=11) and 11.3% (n=17) respectively. Conclusions: It’s important to have knowledge of the percentage recurrence of adnexal masses, histological type that often recur, mean age of presentation, due to diminish ovarian reserve that present with every recurrence, and as seen before, adnexal masses presents during childbearing age.


REFERENCES

  1. Borgfeldt C, Andolf E. Transvaginal sonographicovarian findings in a random sampleof women 25-40 years old. Ultrasound ObstetGynecol. 1999;13(5):345–50.

  2. Mimoun C, Fritel X, Fauconnier A, Deffieux X,Dumont A, Huchon C. Epidemiology of presumedbenign ovarian tumors. J Gynecol ObstetBiol Reprod 2013;42:722–9

  3. ACOG Practice Bulletin No. 174. Evaluationand Management of adnexal masses. ObstetGynecol. 2016; 128 (5):210-226

  4. Brooks SE. Preoperative evaluation of patientswith suspicious ovarian cancer. Gynecol Oncol1994;55: 80-90

  5. Geomini P, Kruitwagen R, Bremer GL, CnossenJ, Mol BW. The accuracy of risk scores inpredicting ovarian malignancy: a systematicreview. Obstet Gynecol 2016 ; 128 (5):384–94

  6. Brown DL, Dudiak KM, Laing FC. Adnexalmasses: US characterization and reporting.Radiology. 2010;254:342–354

  7. CocciaME, Rizzello F, Romanelli C. AdnexalMasses: What is the Role of UltrasonographicImaging? Arch Gynecol Obstet.2014;290:843–854.

  8. Suh-Burgmann E, Kinney W. Potential harmsoutweigh benefits of indefinite monitoring ofstable adnexal masses. Am J Obstet Gynecol2015;213:816.e1-4

  9. Karpelowsky JS, Hei ER, Matthews K. Laparoscopicresection of benign ovarian tumours inchildren with gonadal preservation. PediatrSurg Int 2009;25:251–4

  10. WaxmanM, Boyce JG. Intraperitoneal ruptureof benign cystic ovarian teratoma. Obstet Gynecol.1976;48 (suppl):9S–13S

  11. Nikolaou M, Adonakis G, Zyli P, AndroutsopoulosG, Saltamavros A, Psachoulia C.Transvaginal ultrasound-guided aspiration ofbenign ovarian cysts. J Obstet Gynaecol2014;34:332–5

  12. Garcia-Tejedor A, Castellarnau M, Burdio F,Fernandez E, Marti D, Pla MJ. Ultrasoundguidedaspiration of adnexal cysts with a lowrisk of malignancy: is it a recommendable option?J Ultrasound Med 2015;34:985–91

  13. Chappell CA, Wiesenfeld HC. Pathogenesis,diagnosis, and management of severe pelvicinflammatory disease and tuboovarian abscess.Clin Obstet Gynecol 2012;55:893–903.

  14. Liu X, Yuan L, Shen F. Patterns of and risk factorsfor recurrence in women with ovarian endometriomas.Obstet Gynecol,2007,109(6):1411-1420

  15. Ming Y, Wen-wen W. Risk Factors for Recurrenceof Ovarian Endometriomas after SurgicalExcision. J Huazhong Univ Sci Technol.2014, 34(2): 213-219

  16. Busacca M, Chiaffarino F, Candiani M. Determinantsof long-term clinically detected recurrencerates of deep, ovarian, and pelvic endometriosis.Am JObstet Gynecol.2006;195(2):426–432

  17. Song YN, Zhu L, Lang JH. Recurrent matureovarian teratomas: retrospective analysis of 20cases. Chin Med J 2007; 87(17):1184-6.

  18. Hackethal A, Brueggmann D, Bohlmann MK,Franke FE, Tinneberg HR, Münstedt K. Squamous-cell carcinoma in mature cystic teratomaof the ovary: systematic review and analysis ofpublished data. Lancet Oncol 2008;9:1173-80.

  19. Koga k, osuga Y. Recurrence of endometriomaafter laparoscopic excision and its preventionby medical management. Front biosci.

  20. 2013 (5):676-8320. Tokie H, Tetsuya H. Contralateral ovarian endometriomarecurrence after unilateral salpinoogoophorectomy.BMC women's health.2019; 19:59

  21. Farquhar CM. Extracts from the clinical evidence.Endometriosis. BMJ 2000;320:1449–52




2020     |     www.medigraphic.com